CEP41 Protein (Myc-DYKDDDDK Tag)
-
- Antigène Voir toutes CEP41 Protéines
- CEP41 (Centrosomal Protein 41kDa (CEP41))
- Type de proteíne
- Recombinant
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette CEP41 protéine est marqué à la Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Attributs du produit
-
- Recombinant human TSGA14 / CEP41 protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Pureté
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product CEP41 Protéine
-
-
- Indications d'application
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Commentaires
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Stock
- -80 °C
- Stockage commentaire
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Antigène
- CEP41 (Centrosomal Protein 41kDa (CEP41))
- Autre désignation
- Tsga14,cep41 (CEP41 Produits)
- Synonymes
- 1700017E11Rik Protein, 2810431D15Rik Protein, AI449046 Protein, AI503610 Protein, Tsga14 Protein, JBTS15 Protein, TSGA14 Protein, Cep41-A Protein, tsga14 Protein, RPL37A Protein, centrosomal protein 41 Protein, centrosomal protein 41kDa S homeolog Protein, Cep41 Protein, CEP41 Protein, cep41.S Protein
- Sujet
- This gene encodes a centrosomal and microtubule-binding protein which is predicted to have two coiled-coil domains and a rhodanese domain. In human retinal pigment epithelial cells the protein localized to centrioles and cilia. Mutations in this gene have been associated with Joubert Syndrome 15 an autosomal recessive ciliopathy and neurological disorder. Alternative splicing results in multiple transcript variants.
- Poids moléculaire
- 41.2 kDa
- NCBI Accession
- NP_061188
- Pathways
- M Phase
-